Stay updated on Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial

Sign up to get notified when there's something new on the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Added revision: v3.5.0; deleted revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T17:45:40.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 to reflect the page's latest version.
    Difference
    0.1%
    Check dated 2026-03-11T16:44:23.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added, and the funding-lapse notice has been removed. This update does not modify study content, eligibility criteria, or outcomes.
    Difference
    0.4%
    Check dated 2026-02-11T09:24:37.000Z thumbnail image
  6. Check
    58 days ago
    Change Detected
    Summary
    The page now shows a government funding notice regarding potential delays and open status of the NIH Clinical Center, and the site revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T05:36:51.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Minor UI/metadata updates were made: the glossary option is now shown, revision labels were updated to Revision: v3.4.0 with capitalization tweaks for No FEAR Act data, and older labels such as 'Last Update Submitted that met QC Criteria' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:08:09.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.4, replacing v3.3.3. This is a minor metadata update and does not affect study data, eligibility criteria, or locations.
    Difference
    0.1%
    Check dated 2026-01-14T02:33:19.000Z thumbnail image

Stay in the know with updates to Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Temelimab for Neuropsychiatric Symptoms in Post-COVID: Clinical Trial page.